Index of HIV/AIDS-related articles

This is a list of topics related to HIV/AIDS, a spectrum of conditions caused by human immunodeficiency virus (HIV) infection. Many of the topics listed here were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition. [https://web.archive.org/web/20041105064312/http://aidsinfo.nih.gov//ed_resources/glossary/]

__NOTOC__

A

AACTG –

acquired immunity –

acquired immunodeficiency syndrome (AIDS) –

ACT UP/Golden Gate –

active immunity –

acupuncture –

acute HIV infection –

Acute HIV Infection and Early Diseases Research Program (AIEDRP) –

ADAP –

ADC –

adenopathy –

adherence –

adjuvant –

administration –

Adult AIDS Clinical Trials Group (AACTG) –

adverse drug reaction –

aerosolized –

AETC –

agammaglobulinemia –

Agency for Healthcare Research and Quality (AHRQ) –

AHRQ –

AIDS –

AIDS Arms –

AIDS dementia complex (ADC) –

AIDS Drug Assistance Programs (ADAP) –

AIDS education and training centers (AETC) –

AIDS orphan –

AIDS research advisory committee (ARAC) –

AIDS service organization (ASO) –

The AIDS Show –

AIDS Vaccine 200 –

AIDS Vaccine Advocacy Coalition –

AIDS wasting syndrome –

AIDS-related cancer –

AIDS-related complex (ARC) –

alkaline phosphatase –

alopecia –

alpha interferon (INFa) –

alternative medicine –

alveolar –

amebiasis –

amino acids –

anaphylactic shock –

anemia –

anergy –

angiogenesis –

angiomatosis –

anorexia –

antenatal –

antibiotic –

antibodies –

antibody-dependent cell-mediated cytotoxicity (ADCC) –

antibody-mediated immunity –

antifungal medication –

antigen –

antigen presentation –

antigen-presenting cell (APC) –

antineoplastic –

antiprotozoal –

antiretroviral drugs –

antisense drugs –

antitoxins –

Antiviral drug –

aphasia –

aphthous ulcer –

apoptosis –

approved drugs –

ARC –

Armenicum –

ART –

arthralgia –

ASO –

aspergillosis –

assembly and budding –

asymptomatic –

ataxia –

attenuated –

autoantibody –

autoimmunization –

autoinoculation –

autologous –

avascular necrosis (AVN) –

AVN

B

B-cell lymphoma –

B cells –

B lymphocytes (B cells) –

bactericidal –

bacteriostatic –

bacterium –

baculovirus –

baseline –

basophil –

bDNA test –

beta-2 microglobulin (β2M) –

bilirubin –

bioavailability –

biological response modifiers (BRMs) –

biopsy –

biotechnology –

blinded study –

blips –

blood–brain barrier –

body fat redistribution (BFR) syndrome –

body fluids –

bone marrow –

bone marrow suppression –

booster –

branched DNA assay –

breakthrough infection –

Broadway Cares/Equity Fights AIDS –

bronchoscopy –

budding –

buffalo hump –

bugchasing and giftgiving –

Burkitt's lymphoma

C

C-T scan (computed tomography scan) –

cachexia –

Canadian Foundation for AIDS Research –

candida –

candidiasis –

carcinogen –

CAT scan –

CCR5 –

CD4 (T4) or CD4 + cells –

CDC National Prevention Information Network (CDC-NPIN) –

cell lines –

cell-mediated immunity (CMI) –

cellular immunity –

Centers for Disease Control and Prevention (CDC) –

Centers for Medicare and Medicaid Services (CMS) –

central nervous system –

cerebrum –

cerebrospinal fluid (CSF) –

cervical cancer –

cervical dysplasia –

cervical intraepithelial neoplasia (CIN1, CIN2, CIN3) –

cervix –

chancroid –

chemokines –

chemoprophylaxis –

chemotherapy –

Chlamydia –

chronic idiopathic demyelinating polyneuropathy (CIPD) –

circumoral paresthesia –

clade –

clinical endpoint –

clinical latency –

clinical practice guidelines –

clinical trial –

clinicaltrials.gov –

cloning –

CMS –

CMV –

CNS –

co-receptors –

coccidioidomycosis –

codon –

cofactors –

cognitive impairment –

cohort –

colitis –

combination therapy –

community planning –

Community Programs for Clinical Research on AIDS (CPCRA) –

community-based clinical trial (CBCT) –

community-based organization (CBO) –

compassionate use –

complement –

complement cascade –

complementary and alternative therapy –

complete blood count (CBC) –

computed tomography scan (C-T scan) –

concomitant drugs –

condyloma –

condyloma acuminatum –

contagious –

contraindication –

controlled trials –

core –

core protein –

correlates of immunity/correlates of protection –

creatinine –

cross-resistance –

cryotherapy –

cryptococcal meningitis –

cryptococcosis –

Cryptococcus neoformans –

cryptosporidiosis –

Cryptosporidium –

CSF –

CTL –

cutaneous –

CXCR4 –

cytokines –

cytomegalovirus (CMV) –

Cytomegalovirus retinitis –

cytopenia –

cytotoxic –

cytotoxic T lymphocyte (CTL)

D

DAIDS –

data safety and monitoring board (DSMB) –

deletion –

dementia –

demyelination –

dendrite –

dendritic cells –

deoxyribonucleic acid (DNA) –

Department of Health and Human Services (DHHS/HHS or DHHS) –

desensitization –

diabetes mellitus (DM) –

diagnosis –

diarrhea –

diplopia –

dissemination –

division of acquired immunodeficiency syndrome (DAIDS) –

DNA –

dose-ranging study –

dose-response relationship –

double-blind study –

drug resistance –

drug-drug interaction –

DSMB –

Duffy antigen system –

dysplasia –

dyspnea

E

efficacy –

empirical –

encephalitis –

end-stage disease –

endemic –

endogenous –

endoscopy –

endotoxin –

endpoint –

enteric –

enteritis –

entry inhibitors –

Env –

envelope –

enzyme –

enzyme-linked immunosorbent assay (ELISA) –

eosinophil –

eosinophilic folliculitis –

epidemic –

epidemiological surveillance –

epidemiology –

epithelium –

epitope –

Epstein-Barr virus (EBV) –

erythema –

erythema multiforme –

erythrocytes –

etiology –

exogenous –

exotoxin –

expanded access –

experimental drug –

expression system

F

fat redistribution –

FDA

FDC –

floaters –

follicle –

follicular dendritic cells (FDCs) –

Food and Drug Administration (United States)

functional antibody –

fungus –

fusin –

fusion inhibitor –

fusion mechanism –

fusion peptide

G

GAG –

gamma globulin –

gamma interferon –

ganglion –

GART –

gastrointestinal (GI) –

gene –

gene therapy –

genetic engineering –

genital ulcer disease –

genital warts –

genitourinary tract –

genome –

genotypic assay –

germinal centers –

giardiasis –

globulins –

glycoprotein –

gonorrhea –

gp120 (gp120) –

gp160 (gp160) –

gp41 (gp41) –

granulocyte –

granulocyte macrophage-colony stimulating factor (GM-CSF) –

granulocyte-colony stimulating factor (G-CSF) –

granulocytopenia

H

HAART –

hairy leukoplakia –

half-life –

HAM/TSP –

Health Care Financing Administration (HCFA) –

Health Resources and Services Administration (HRSA) –

HELLP syndrome –

helper T cells –

helper/suppressor ratio (of T cells) –

hematocrit –

hematotoxic –

hemoglobin –

hemolysis –

hemophilia –

hepatic –

hepatic steatosis –

hepatitis –

hepatitis C and HIV coinfection –

hepatomegaly –

herpes simplex virus 1 (HSV-1) –

herpes simplex virus 2 (HSV-2) –

herpes varicella zoster virus (VZV) –

herpes viruses –

highly active antiretroviral therapy (HAART) –

histocompatibility testing –

histoplasmosis –

HIV disease –

HIV prevention trials network (HPTN) –

HIV set point –

HIV vaccine trials network (HVTN) –

HIV-1 –

HIV-2 –

HIV-associated dementia –

HIV-related tuberculosis –

HLA –

Hodgkin's disease –

holistic medicine –

homology (biology) –

hormone –

host –

host factors –

HPTN –

HPV –

HRSA –

HTLV-I –

HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) –

HTLV-II –

human growth hormone (HGH) –

human immunodeficiency virus type 1 (HIV-1) –

human immunodeficiency virus type 2 (HIV-2) –

human leukocyte antigens (HLA) –

human papilloma virus (HPV) –

human T cell lymphotropic virus type I (HTLV-I) –

human T cell lymphotropic virus type II (HTLV-II) –

humoral immunity –

HVTN –

hydroxyurea –

hypergammaglobulinemia –

hyperglycemia –

hyperlipidemia –

hyperplasia –

hyperthermia –

hypogonadism –

hypothesis –

hypoxia

I

idiopathic –

idiopathic thrombocytopenia purpura –

IHS –

immune complex –

immune deficiency/immunodeficiency –

immune response –

immune system –

immune thrombocytopenic purpura –

immunity –

immunization –

immunocompetent –

immunocompromised –

immunodeficiency –

immunogen –

immunogenicity –

immunoglobulin (Ig) –

immunoglobulin A (IgA) –

immunoglobulin D (IGD) –

immunoglobulin E (IGE) –

immunoglobulin G (IGG) –

immunoglobulin M (IGM) –

immunomodulator –

immunostimulant –

immunosuppression –

immunotherapy –

immunotoxin –

in vitro –

in vivo –

incidence –

Incubation period –

IND –

Indian Health Service (IHS) –

infection –

infectious –

informed consent –

infusion –

inoculation –

institutional review board (IRB) –

integrase –

integrase inhibitors –

Interaction –

interferon –

interleukin-1 (IL-1) –

interleukin-2 (IL-2) –

interleukin-4 (IL-4) –

interleukin-12 (IL-12) –

interleukins –

International Center for Research on Women –

intramuscular (IM) –

intravenous –

intravenous immunoglobulin (IVIG) –

intravitreal –

Investigational New Drug (IND) –

IRB –

ITP –

IVIG

J

jaundice –

JC virus

K

Kaposi's sarcoma (KS) –

Karnofsky score –

killer T cells –

KSHV –

Kupffer cells

L

Langerhans cells –

LAS –

lentivirus –

lesion –

leukocytes –

leukocytosis –

leukopenia –

leukoplakia –

LFT –

LIP –

lipid –

lipodystrophy –

liposomes –

live vector vaccine –

liver function test (LFT) –

long terminal repeat sequence (LTR) –

long-term nonprogressors –

LTR –

lumbar –

lumbar puncture –

lymph –

lymph nodes –

lymphadenopathy syndrome (LAS) –

lymphatic vessels –

lymphocyte –

lymphoid interstitial pneumonitis (LIP) –

lymphoid organs –

lymphoid tissue –

lymphokine-activated killer cells (LAK) –

lymphokines –

lymphoma –

lymphopenia –

lymphoproliferative response –

lysis

M

MAC –

macrophage –

macrophage-tropic virus –

magnetic resonance imaging (MRI) –

MAI –

maintenance therapy –

major histocompatibility complex (MHC) –

malabsorption syndrome –

malaise –

malignant –

mast cell –

MedlinePlus –

mega-HAART –

memory T cells –

meninges –

meningitis –

messenger RNA –

metabolism –

metastasis –

MHC –

microbes –

microbicide –

Microsporidiosis –

mitochondria –

mitochondrial toxicity –

molecule –

molluscum contagiosum –

monocyte –

mononeuritis multiplex (MM) –

monovalent vaccine –

morbidity –

MRI –

mucocutaneous –

mucosa –

mucosal immunity –

mucous membrane –

Multicenter AIDS Cohort Study –

multi-drug rescue therapy –

multiple drug-resistant tuberculosis (MDR-TB) –

mutation –

myalgia –

mycobacterium –

mycobacterium avium complex (MAC) –

mycosis –

myelin –

myelopathy –

myelosuppression –

myelotoxic –

myocardial –

myopathy

N

NAT –

National Cancer Institute (NCI) –

National Institute of Allergy and Infectious Diseases (NIAID) –

National Institute of Child Health and Human Development (NICHD) –

National Institutes of Health (NIH) –

National Library of Medicine (NLM) –

National Prevention Information Network (NPIN) –

natural history study –

natural killer cells (NK cells) –

NCI –

New Drug Application –

nebulized –

Nef –

neoplasm –

nephrotoxic –

neuralgia –

neurological complications of AIDS –

neuropathy –

neutralization –

neutralizing antibody –

neutralizing domain –

neutropenia –

neutrophil –

New Drug Application (NDA) –

New York Cares –

NIAID –

NICHD –

night sweat –

NIH –

NK cell –

NLM –

NNRTI –

non-Hodgkin's lymphoma (NHL) –

non-nucleoside reverse transcriptase inhibitors (NNRTI) –

non-steroidal anti-inflammatory drugs (NSAID) –

NRTI –

nucleic acid –

nucleic acid test –

nucleocapsid –

nucleoli –

nucleoside –

nucleoside analog –

nucleoside reverse transcriptase inhibitors (NRTI) –

nucleotide –

nucleotide analogs –

nucleus –

null cell

O

ocular –

off-label use –

oncology –

open-label trial –

opportunistic infections –

oral hairy leukoplakia (OHL) –

organelle –

oropharyngeal –

orphan drugs –

osteonecrosis –

osteopenia

P

P24 –

package insert –

palliative –

palliative care –

pancreas –

pancreatitis –

pancytopenia –

pandemic –

pap smear –

papilloma –

parallel track –

parasite –

parenteral –

paresthesia –

passive immunity –

passive immunotherapy –

pathogen –

pathogenesis –

PBMC –

PCP –

PCR –

Pediatric AIDS Clinical Trial Group (PACTG) –

pelvic inflammatory disease –

peptide –

perianal –

perinatal –

perinatal transmission –

peripheral neuritis –

peripheral neuropathy –

persistent generalized lymphadenopathy –

PGL –

phagocyte –

phagocytosis –

pharmacokinetics –

phase I trials –

phase II trials –

phase III trials –

phase IV trials –

photosensitivity –

PHS –

pituitary gland –

placebo –

placebo controlled study –

placebo effect –

plasma –

plasma cells –

platelets –

PML –

Pneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) –

POL –

polymerase –

polymerase chain reaction (PCR) –

polyneuritis –

polypeptide –

polyvalent vaccine –

post-exposure prophylaxis (PEP) –

PPD test –

pre-conception counseling –

preclinical –

precursor cells –

prevalence –

primary HIV infection –

primary isolate –

primaquine –

proctitis –

prodrome –

prodrug –

progressive multifocal leukoencephalopathy (PML) –

prophylactic drug –

prophylaxis –

protease –

protease inhibitors –

protease-sparing regimen –

proteins –

protocol –

protozoa –

provirus –

pruritus –

pseudo-Cushing's syndrome –

pseudovirion –

PUBMED –

pulmonary –

purified protein derivative (PPD)

R

radiology –

randomized trial –

rebound –

receptor (immunology) –

recombinant –

recombinant DNA –

recombinant DNA technology –

regulatory genes –

regulatory T cells –

remission –

renal –

rescue therapy –

resistance –

retina –

retinal detachment –

retinitis –

retrovirus –

REV –

reverse transcriptase –

ribonucleic acid (RNA) –

ribosome –

riboviria –

RNA –

route of administration –

RT-PCR –

RTI –

Ryan White C.A.R.E. act

S

safe sex –

safer sex –

salmonella –

salvage therapy –

SAMHSA –

sarcoma –

seborrheic dermatitis –

secondary prophylaxis –

sepsis –

seroconversion –

serologic test –

seroprevalence –

serosorting –

serostatus –

serum –

serum glutamic oxaloacetic transaminase (SGOT) –

serum glutamic pyruvate transaminase (SGPT) –

sexually transmitted disease (STD) –

shingles –

SHIV –

side effects –

simian immunodeficiency virus (SIV) –

sinusitis –

social integration

SIT –

SIV –

Special Projects of National Significance (SPNS) –

spinal tap –

spleen –

splenomegaly –

sputum analysis –

standard of care –

staphylococcus –

STD –

stem cells (FDCs) –

steroid –

Stevens–Johnson syndrome –

STI –

stomatitis –

strain –

stratification –

structured intermittent therapy (SIT) –

structured treatment interruption (STI) –

study endpoint –

subarachnoid space –

subclinical infection –

subcutaneous (SQ) –

Substance Abuse and Mental Health Services Administration (SAMHSA) –

subunit HIV vaccine –

sulfa drug –

sulfonamides –

superantigen –

suppressor T cell –

surrogate marker –

surveillance –

susceptible –

symptoms –

syncytium –

syndrome –

synergy –

synergistic –

synthesis –

syphilis –

systemic

T

T cells (T lymphocytes) –

T lymphocyte proliferation assay –

T lymphocytes –

T suppressor cells –

T4 cells (T-helper cells) –

T8 cells –

Tanner staging –

TAT –

TB –

template –

TeachAids –

teratogenicity –

testosterone –

therapeutic HIV vaccine –

thrombocytopenia –

thrush –

thymosin –

thymus –

tissue –

titer –

toxicity –

toxoplasmic encephalitis –

toxoplasmosis –

transaminase –

transcription –

transfusion –

translation –

transmission –

transplacental –

treatment IND –

triglycerides –

tuberculin skin test (TST) –

tuberculosis (TB) –

tumor necrosis factor (TNF)

V

V3 loop –

vaccination –

vaccine –

vaccinia –

vaginal candidiasis –

valley fever –

variable region –

varicella zoster virus (VZV) –

vector –

vertical transmission –

viral burden –

viral core –

viral culture –

viral envelope –

viral load –

viremia –

viricide –

virion –

virology –

virus –

visceral

W

wasting syndrome –

Western blot –

white blood cells –

wild-type virus –

window period –

Women's Interagency HIV Study (WIHS) –

World AIDS Day –

World AIDS Vaccine Day

Y

yeast infection – Youth Against AIDS

Z

zinc finger inhibitor –

zinc fingers